Richard K Wyse, Tom Isaacs, Roger A Barker, Mark R Cookson, Ted M Dawson, David Devos, David T Dexter, Joy Duffen, Howard Federoff, Brian Fiske, Thomas Foltynie, Susan Fox, J Timothy Greenamyre, Karl Kieburtz, Jeffrey H Kordower, Dimitri Krainc, Helen Matthews, Darren J Moore, Leah Mursaleen, Michael A Schwarzschild, Simon R W Stott, David Sulzer, Per Svenningsson, Caroline M Tanner, Camille Carroll, David K Simon, Patrik Brundin
In 2011, the UK medical research charity Cure Parkinson's set up the international Linked Clinical Trials (iLCT) committee to help expedite the clinical testing of potentially disease modifying therapies for Parkinson's disease (PD). The first committee meeting was held at the Van Andel Institute in Grand Rapids, Michigan in 2012. This group of PD experts has subsequently met annually to assess and prioritize agents that may slow the progression of this neurodegenerative condition, using a systematic approach based on preclinical, epidemiological and, where possible, clinical data...
April 5, 2024: Journal of Parkinson's Disease